The nature of the reverse type I (modified type II) spectral change in liver microsomes.
D000438:Alcohols / Q000494:pharmacology; D000632:Aminopyrine / Q000378:metabolism; D000814:Aniline Compounds / Q000494:pharmacology; D000818:Animals; D001580:Benzopyrenes / Q000494:pharmacology; D001665:Binding Sites; D002248:Carbon Monoxide / Q000378:metabolism; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D004357:Drug Synergism; D006591:Hexobarbital / Q000378:metabolism; D008297:Male; D008748:Methylcholanthrene / Q000494:pharmacology; D008862:Microsomes, Liver / Q000187:drug effects / Q000378:metabolism; D010084:Oxidation-Reduction; D010088:Oxidoreductases / Q000378:metabolism; D010615:Phenacetin / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D013045:Species Specificity; D013053:Spectrophotometry; D013056:Spectrophotometry, Ultraviolet
D000438:Alcohols; D000814:Aniline Compounds; D001580:Benzopyrenes; D000632:Aminopyrine; D008748:Methylcholanthrene; D002248:Carbon Monoxide; D003577:Cytochrome P-450 Enzyme System; D006591:Hexobarbital; D010088:Oxidoreductases; D010615:Phenacetin